HCPCS Level IIdrugActive
J2277
Inj, motixafortide, 0.25 mg
BETOS: O1E
Effective: 2024-04-01
Description
Injection, motixafortide, 0.25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Aphexda
Manufacturer
BioLineRx USA, Inc.
HCPCS Dosage
0.25 MG
Billing Units
248.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.